title: IBS, NERD and functional dyspepsia are immuno-neuronal disorders of mucosal cytokine imbalances clinically reversible with high potency sucralfate.
abstract: Irritable bowel syndrome (IBS), non-erosive reflux disorder (NERD), and functional dyspepsia (FD) are best classified as immuno-neuronal disorders of the mucosa or functional mucosal syndromes (FMS). Each appears to be clinically reversible using high potency sucralfate (HPS). In FMS of the GI tract, postprandial nausea, altered motility, discordant peristalsis, vomiting, diarrhea, and hyperalgesia are the clinical expressions of a mucosal imbalance between pro-inflammatory cytokines of up-regulated intra-epithelial lymphocytes (IELs) and feedback anti-inflammatory cytokines tasked with moderating the antigenic response of IELs. Normal functioning GI tract requires an operative balance between pro-inflammatory and anti-inflammatrory cytokines, a balance governed by locally expressed growth factors. The surface concentration of sucralfate can be enhanced 7-23-fold by suspending it in a select concentration of cations and multi-dentate cationic chelators. Increased surface concentration of sucralfate facilitates novel dose effects which include efficient activation of growth factors, quiescence of gated-nociceptor firing and resultant restoration of normal GI function.
authors.affiliation: Department of Medicine, Providence Veterans Administration Medical Center, Brown University Teaching Hospital, 830 Chaulkstone Avenue, Providence RI 02904, USA. glencopelph@aol.com
authors.forename: Ricky W
authors.initials: RW
authors.lastname: McCullough
mesh_terms: D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D016207:Cytokines / Q000502:physiology*; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D009092:Mucous Membrane / Q000503:physiopathology*; D013392:Sucralfate / Q000627:therapeutic use*
chemical_list: D000897:Anti-Ulcer Agents; D016207:Cytokines; D013392:Sucralfate